Premium
Sonnet BioTherapeutics Holdings Inc (SONN)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet") (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic...
The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at any dose level Stable disease (SD) at four months...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.83 | -31.2030075188 | 2.66 | 4.85 | 1.66 | 10461982 | 1.98026687 | CS |
| 4 | -1.18 | -39.2026578073 | 3.01 | 4.85 | 1.66 | 2694251 | 2.00563531 | CS |
| 12 | -6.1452 | -77.0538669877 | 7.9752 | 10.02 | 1.66 | 1355938 | 2.63487506 | CS |
| 26 | -13.53 | -88.0859375 | 15.36 | 15.84 | 1.66 | 710133 | 3.02437155 | CS |
| 52 | -10.65 | -85.3365384615 | 12.48 | 18.7192 | 1.66 | 391996 | 4.07543992 | CS |
| 156 | -1304.09 | -99.8598689047 | 1305.92 | 1649.4016 | 1.66 | 1957964 | 568.94235251 | CS |
| 260 | -15324.25 | -99.988059569 | 15326.08 | 39916.8 | 1.66 | 2340061 | 2552.4161161 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
